144 related articles for article (PubMed ID: 38732102)
1. Structure-Function Analysis of the Essential
Padayachee T; Lamb DC; Nelson DR; Syed K
Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38732102
[TBL] [Abstract][Full Text] [Related]
2. Acetylene containing cyclo(L-Tyr-L-Tyr)-analogs as mechanism-based inhibitors of CYP121A1 from Mycobacterium tuberculosis.
Ortega Ugalde S; Wallraven K; Speer A; Bitter W; Grossmann TN; Commandeur JNM
Biochem Pharmacol; 2020 Jul; 177():113938. PubMed ID: 32224137
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis and evaluation against Mycobacterium tuberculosis of azole piperazine derivatives as dicyclotyrosine (cYY) mimics.
El-Wahab HAAA; Accietto M; Marino LB; McLean KJ; Levy CW; Abdel-Rahman HM; El-Gendy MA; Munro AW; Aboraia AS; Simons C
Bioorg Med Chem; 2018 Jan; 26(1):161-176. PubMed ID: 29183661
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and biological evaluation of novel cYY analogues targeting Mycobacterium tuberculosis CYP121A1.
Kishk SM; McLean KJ; Sood S; Helal MA; Gomaa MS; Salama I; Mostafa SM; de Carvalho LPS; Munro AW; Simons C
Bioorg Med Chem; 2019 Apr; 27(8):1546-1561. PubMed ID: 30837169
[TBL] [Abstract][Full Text] [Related]
5. Novel Aryl Substituted Pyrazoles as Small Molecule Inhibitors of Cytochrome P450 CYP121A1: Synthesis and Antimycobacterial Evaluation.
Taban IM; Elshihawy HEAE; Torun B; Zucchini B; Williamson CJ; Altuwairigi D; Ngu AST; McLean KJ; Levy CW; Sood S; Marino LB; Munro AW; de Carvalho LPS; Simons C
J Med Chem; 2017 Dec; 60(24):10257-10267. PubMed ID: 29185746
[TBL] [Abstract][Full Text] [Related]
6. Substrate and reaction specificity of Mycobacterium tuberculosis cytochrome P450 CYP121: insights from biochemical studies and crystal structures.
Fonvielle M; Le Du MH; Lequin O; Lecoq A; Jacquet M; Thai R; Dubois S; Grach G; Gondry M; Belin P
J Biol Chem; 2013 Jun; 288(24):17347-59. PubMed ID: 23620594
[TBL] [Abstract][Full Text] [Related]
7. Structural Characterization and Ligand/Inhibitor Identification Provide Functional Insights into the Mycobacterium tuberculosis Cytochrome P450 CYP126A1.
Chenge JT; Duyet LV; Swami S; McLean KJ; Kavanagh ME; Coyne AG; Rigby SE; Cheesman MR; Girvan HM; Levy CW; Rupp B; von Kries JP; Abell C; Leys D; Munro AW
J Biol Chem; 2017 Jan; 292(4):1310-1329. PubMed ID: 27932461
[TBL] [Abstract][Full Text] [Related]
8. Structural biology and biochemistry of cytochrome P450 systems in Mycobacterium tuberculosis.
McLean KJ; Munro AW
Drug Metab Rev; 2008; 40(3):427-46. PubMed ID: 18642141
[TBL] [Abstract][Full Text] [Related]
9. Surface hydrophobics mediate functional dimerization of CYP121A1 of Mycobacterium tuberculosis.
Kumar A; Campomizzi CS; Jay N; Ferguson S; Scheffler EJ; Lioi J; Tu C; Qu J; Simons C; Estrada DF
Sci Rep; 2021 Jan; 11(1):394. PubMed ID: 33431984
[TBL] [Abstract][Full Text] [Related]
10. The Structure of Mycobacterium tuberculosis CYP125: molecular basis for cholesterol binding in a P450 needed for host infection.
McLean KJ; Lafite P; Levy C; Cheesman MR; Mast N; Pikuleva IA; Leys D; Munro AW
J Biol Chem; 2009 Dec; 284(51):35524-33. PubMed ID: 19846552
[TBL] [Abstract][Full Text] [Related]
11. Crystal structure of the Mycobacterium tuberculosis P450 CYP121-fluconazole complex reveals new azole drug-P450 binding mode.
Seward HE; Roujeinikova A; McLean KJ; Munro AW; Leys D
J Biol Chem; 2006 Dec; 281(51):39437-43. PubMed ID: 17028183
[TBL] [Abstract][Full Text] [Related]
12. Potential drug targets in the Mycobacterium tuberculosis cytochrome P450 system.
Ortiz de Montellano PR
J Inorg Biochem; 2018 Mar; 180():235-245. PubMed ID: 29352597
[TBL] [Abstract][Full Text] [Related]
13. Fragment Profiling Approach to Inhibitors of the Orphan M. tuberculosis P450 CYP144A1.
Kavanagh ME; Chenge J; Zoufir A; McLean KJ; Coyne AG; Bender A; Munro AW; Abell C
Biochemistry; 2017 Mar; 56(11):1559-1572. PubMed ID: 28169518
[TBL] [Abstract][Full Text] [Related]
14. Active Site Aromatic Residues Play a Dual Role in the Substrate Interaction and Protein Structure in Functional Dimers of CYP121A1 of
Campomizzi CS; Kumar A; Uttamrao PP; Stallone JJ; Ghanatios GE; Rathinavelan T; Estrada DF
ACS Infect Dis; 2023 Apr; 9(4):827-839. PubMed ID: 36976833
[TBL] [Abstract][Full Text] [Related]
15. Structure, function and drug targeting in Mycobacterium tuberculosis cytochrome P450 systems.
McLean KJ; Dunford AJ; Neeli R; Driscoll MD; Munro AW
Arch Biochem Biophys; 2007 Aug; 464(2):228-40. PubMed ID: 17482138
[TBL] [Abstract][Full Text] [Related]
16. A comparison of steroid and lipid binding cytochrome P450s from Mycobacterium marinum and Mycobacterium tuberculosis.
Child SA; Ghith A; Bruning JB; Bell SG
J Inorg Biochem; 2020 Aug; 209():111116. PubMed ID: 32473484
[TBL] [Abstract][Full Text] [Related]
17.
Campomizzi CS; Ghanatios GE; Estrada DF
J Biol Chem; 2021 Nov; 297(5):101287. PubMed ID: 34634307
[TBL] [Abstract][Full Text] [Related]
18. Characterization of active site structure in CYP121. A cytochrome P450 essential for viability of Mycobacterium tuberculosis H37Rv.
McLean KJ; Carroll P; Lewis DG; Dunford AJ; Seward HE; Neeli R; Cheesman MR; Marsollier L; Douglas P; Smith WE; Rosenkrands I; Cole ST; Leys D; Parish T; Munro AW
J Biol Chem; 2008 Nov; 283(48):33406-16. PubMed ID: 18818197
[TBL] [Abstract][Full Text] [Related]
19. Crystal structure of cytochrome P450 14alpha -sterol demethylase (CYP51) from Mycobacterium tuberculosis in complex with azole inhibitors.
Podust LM; Poulos TL; Waterman MR
Proc Natl Acad Sci U S A; 2001 Mar; 98(6):3068-73. PubMed ID: 11248033
[TBL] [Abstract][Full Text] [Related]
20. Cytochromes P450: novel drug targets in the war against multidrug-resistant Mycobacterium tuberculosis.
Munro AW; McLean KJ; Marshall KR; Warman AJ; Lewis G; Roitel O; Sutcliffe MJ; Kemp CA; Modi S; Scrutton NS; Leys D
Biochem Soc Trans; 2003 Jun; 31(Pt 3):625-30. PubMed ID: 12773169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
